Key clinical point: Cannabinoids added to opioids did not reduce mean patient-reported pain scores.
Major finding: There was no significant difference in the mean difference in pain intensity between cannabinoids and placebo.
Study details: Systematic review and meta-analysis of five randomized controlled trials with 1,442 participants.
Disclosures: The authors did not report a funding source. No conflicts of interest were reported.
Boland EG et al. BMJ Supportive & Palliative Care 2020 Jan 20. doi: 10.1136/bmjspcare-2019-002032.
This Week's Must Reads
Must Reads in Opioid Resource Center
Sickle cell pain: Opioids appear safe for inpatients, Akinboro OA et al. ASH 2018, Abstract 315